11.12.2014
- Merck & Co has said it will proceed with its planned $8.4 billion acquisition of Cubist Pharmaceuticals in the first quarter of 2015 and still expects the deal to boost its long...
01.07.2013
- European regulators have cleared the way for the first serious threat to the makers of multibillion-dollar biotechnology drugs to treat diseases such as cancer and rheumatoid...
07.11.2012
- Hospira on Wednesday posted a net profit for the third quarter compared with a year-earlier loss as sales rose slightly, and backed its outlook for the full year. Net earnings were...
25.09.2012
- Pharmaceuticals - Of the many challenges inherent with biosimilar development, the inability to predict market expectations may top the list for decision makers. While uncertainty...
03.08.2012
- German healthcare conglomerate Fresenius may raise its 2012 profit outlook for a third time this year as its injectable generic drugs unit Kabi continues to benefit from rivals'...
21.07.2012
- Aggressive consolidation among U.S. and European generic drugmakers is putting pressure on smaller competitors in the industry, whose best hope of surviving a brewing price war may...
22.12.2011
- The European Union on Tuesday strengthened export controls on drugs that can be used to administer the death penalty, putting a further squeeze on a supply shortage that has slowed...
30.05.2011
- Doubled-Edged Sword - The emergence of biosimilars has caused very large ripples in the biopharma pond, and has recently been called the most "disruptive technology" of the decade...
